The p53 pathway encounters the microRNA world

Current Genomics

Volumn 10, Issue 3, 2009, Pages 194-197

  Takwi, Apana ^a   Li, Yong ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

MicroRNA; P53

Indexed keywords

MICRORNA; MICRORNA 17; MICRORNA 192; MICRORNA 194; MICRORNA 21; MICRORNA 215; MICRORNA 29; MICRORNA 34; MICRORNA 372; MICRORNA 373; MICRORNA 92; NUCLEIC ACID; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; CARCINOGENESIS; CELL CYCLE ARREST; CELL SURVIVAL; DOWN REGULATION; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE LOSS; GENE OVEREXPRESSION; GENE REGULATORY NETWORK; GENE TARGETING; HUMAN; NONHUMAN; PROTEIN FUNCTION; PROTEIN RNA BINDING; REVIEW; RNA ANALYSIS; SENESCENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WILD TYPE;

EUKARYOTA;

EID: 68649113121     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920209788185270     Document Type: Review

References (36)

1. Hollstein, M., Sidransky, D., Vogelstein, B., Harris, C.C. p53 mutations in human cancers. Science 1991, 253(5015): 49-53.
2. Soussi, T. p53 alterations in human cancer: more questions than answers. Oncogene 2007; 26(15): 2145-56.
3. Vousden, K.H., Lane, D.P. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 2007, 8(4): 275-83.
4. Fei, P., Bernhard, E.J., El-Deiry, W.S. Tissue-specific induction of p53 targets in vivo. Cancer Res. 2002, 62(24): 7316-27.
5. Hermeking, H., Lengauer, C., Polyak, K., He, T.C., Zhang, L., Thiagalingam, S., Kinzler, K.W., Vogelstein, B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1997, 1(1): 3-11.
6. Yu, J., Zhang, L., Hwang, P.M., Kinzler, K.W., Vogelstein, B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell 2001, 7(3): 673-82.
7. Spurgers, K.B., Gold, D.L., Coombes, K.R., Bohnenstiehl, N.L., Mullins, B., Meyn, R.E., Logothetis, C.J., McDonnell, T.J. Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression. J. Biol. Chem. 2006, 281(35): 25134-42.
8. Meister, G., Tuschl, T. Mechanisms of gene silencing by double-stranded RNA. Nature 2004, 431(7006): 343-9.
9. de Moor, C.H., Meijer, H., Lissenden, S. Mechanisms of translational control by the 3′ UTR in development and differentiation. Semin. Cell Dev. Biol. 2005, 16(1): 49-58.
10. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P., Burge, C.B. Prediction of mammalian microRNA targets. Cell 2003, 115(7): 787-98.
11. Kloosterman, W.P, Plasterk, R.H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 2006, 11(4): 441-50.
12. Cummins, J.M., Velculescu, V.E. Implications of micro-RNA profiling for cancer diagnosis. Oncogene 2006, 25(46): 6220-7.
13. Garzon, R., Fabbri, M., Cimmino, A., Calin, G.A., Croce, C.M. MicroRNA expression and function in cancer. Trends Mol. Med. 2006, 12(12): 580-7.
14. He, L., He, X., Lim, L.P., de Stanchina, E., Xuan, Z., Liang, Y., Xue W., Zender, L., Magnus, J., Ridzon, D., Jackson, A.L., Linsley, P.S., Chen, C., Lowe, S.W., Cleary, M.A., Hannon, G.J. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447(7148): 1130-4.
15. Tazawa, H., Tsuchiya, N., Izumiya, M., Nakagama, H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. USA 2007, 104(39): 15472-7.
16. Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007, 6(13): 1586-93.
17. Bommer, G.T., Gerin, I., Feng, Y., Kaczorowski, A.J., Kuick, R., Love, R.E., Zhai, Y., Giordano, T.J., Qin, Z.S., Moore, B.B., MacDougald, O.A., Cho, K.R., Fearon, E.R. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 2007, 17(15): 1298-307.
18. Yamakuchi, M., Ferlito, M., Lowenstein, C.J. miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. USA 2008, 105(36): 13421-6.
19. Longo, V.D., Kennedy, B.K. Sirtuins in aging and age-related disease. Cell 2006, 126: 257-268.
20. Yeung, F., Hoberg, J.E., Ramsey, C.S., Keller, M.D., Jones, D.R., Frye, R.A., Mayo, M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23: 2369-2380.
21. Cheng, H.-L., Mostoslavsky, R., Saito, S., Manis, J.P., Gu, Y., Patel, P., Bronson, R., Appella, E., Alt, F.W. Chua, K.F. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. USA 2003, 100: 10794-10799.
22. Ji, Q., Hao, X., Meng, Y., Zhang, M., Desano, J., Fan, D., Xu, L. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008, 8: 266.
23. Reif, K., Gout, I., Waterfield, M.D., Cantrell, D.A. Divergent regulation of phosphatidylinositol 3-kinase P85 alpha and P85 beta isoforms upon T cell activation. J. Biol. Chem. 1993, 268: 10780-10788.
24. Park, S.Y., Lee, J.H., Ha, M., Nam, J.W., Kim, V.N. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat. Struct. Mol. Biol. 2009, 16(1): 23-9.
25. Ellenbroek, S.I., Collard, J.G. Rho GTPases: functions and association with cancer. Clin. Exp. Metastasis 2007, 24(8): 657-72.
26. Braun, C.J., Zhang, X., Savelyeva, I., Wolff, S., Moll, U.M., Schepeler, T., Ørntoft, T.F., Andersen, C.L., Dobbelstein, M. p53-Responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 2008, 68(24): 10094-104.
27. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A.O., Landthaler, M., Lin, C., Socci, N.D., Hermida, L., Fulci, V., Chiaretti, S., Foà, R., Schliwka, J., Fuchs, U., Novosel, A., Müller, R.U., Schermer, B., Bissels, U., Inman, J., Phan, Q., Chien, M., Weir, D.B., Choksi, R., De Vita, G., Frezzetti, D., Trompeter, H.I., Hornung, V., Teng, G., Hartmann, G., Palkovits, M., Di Lauro, R., Wernet, P., Macino, G., Rogler, C.E., Nagle, J.W., Ju, J., Papavasiliou, F.N., Benzing, T., Lichter, P., Tam, W., Brownstein, M.J., Bosio, A., Borkhardt, A., Russo, J.J., Sander, C., Zavolan, M., Tuschl, T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129(7): 1401-14.
28. Georges, S.A., Biery, M.C., Kim, S.Y., Schelter, J.M., Guo, J., Chang, A.N., Jackson, A.L., Carleton, M.O., Linsley, P.S., Cleary, M.A., Chau, B.N. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Res. 2008, 68(24): 10105-12.
29. Voorhoeve, P.M., le Sage, C., Schrier, M., Gillis, A.J., Stoop, H., Nagel, R., Liu, Y.P., van Duijse, J., Drost, J., Griekspoor, A., Zlotorynski, E., Yabuta, N., De Vita, G., Nojima, H., Looijenga, L.H., Agami, R. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Adv. Exp. Med. Biol. 2006, 604: 17-46.
30. Xu, T., Wang, W., Zhang, S., Stewart, R.A., Yu, W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 1995, 121, 1053-1063.
31. McPherson, J.P., Tamblyn, L., Elia, A., Migon, E., Shehabeldin, A., Matysiak-Zablocki, E., Lemmers, B., Salmena, L., Hakem, A., Fish, J., Kassam, F., Squire, J., Bruneau, B.G., Hande, M.P., Hakem, R. Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J. 2004, 23, 3677-3688.
32. Li, Y., Pei, J., Xia, H., Ke, H., Wang, H., Tao, W. Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 2003; 22, 4398-4405.
33. Toji, S., Yabuta, N., Hosomi, T., Nishihara, S., Kobayashi, T., Suzuki, S., Tamai, K., Nojima, H. The centrosomal protein Lats2 is a phosphorylation target of Aurora-A kinase. Genes Cells 2004, 9, 383-397.
34. Xiao, C., Srinivasan, L., Calado, D.P., Patterson, H.C., Zhang, B., Wang, J., Henderson, J.M., Kutok, J.L., Rajewsky, K. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 2008, 9(4): 405-14.
35. Inomata, M., Tagawa, H., Guo, Y.M., Kameoka, Y., Takahashi, N., Sawada, K. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 2009, 113(2): 396-402.
36. Papagiannakopoulos, T., Shapiro, A., Kosik, K.S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 2008, 68(19): 8164-72.